THE INFLUENCE OF ERYTHROPOIETIN TREATMENT ON THE BLOOD PRESSURE AND LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH CHRONIC RENAL FAILURE AFTER RENAL TRANSPLANTATION

2004 ◽  
Vol 22 (Suppl. 2) ◽  
pp. S362
Author(s):  
M. Vretenarska ◽  
E. Paskalev ◽  
N. Stojanova ◽  
P. Simeonov
2004 ◽  
Vol 286 (4) ◽  
pp. R793-R800 ◽  
Author(s):  
Marc Conti ◽  
Isabelle M. Renaud ◽  
Bruno Poirier ◽  
Odile Michel ◽  
Marie-France Belair ◽  
...  

Chronic renal failure often induces left ventricular hypertrophy. We assessed whether the heart is affected in the Zucker obese rat, a model of chronic renal failure associated with obesity, glucose intolerance, and insulin resistance without hypertension or hyperglycemia. After systemic blood pressure measurement, the heart, the aorta, and the kidneys were removed from anesthetized 9- and 13-mo-old Zucker obese and lean control male rats ( n = 33, n = 24, n = 25, and n = 21, respectively). Determination of left ventricular geometry, quantification of myocardium collagen density, and measurement of heart antioxidant enzyme activity were made, as well as aorta and kidney parameters. Mean blood pressure remained at a normal range whatever the age and group considered. Whereas kidney structure and function were severely impaired, no sign of myocardial infarction or inflammatory process was noticed. A moderate left ventricular hypertrophy was observed in 13-mo-old obese rats. While heart malondialdehyde was stable with age and among groups, antioxidant enzyme activity was higher in obese rats. In conclusion, in the absence of hypertensive or hyperglycemic disorders, the heart seems to display a sufficient line of defense against oxidative stress during the development of cardiac hypertrophy.


1994 ◽  
Vol 24 (5) ◽  
pp. 768-776 ◽  
Author(s):  
Sally C. Greaves ◽  
Greg D. Gamble ◽  
John F. Collins ◽  
Gillian A. Whalley ◽  
D. Norman Sharpe

Sign in / Sign up

Export Citation Format

Share Document